JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

MYCOBIOLOGY is an esteemed open-access journal published by Taylor & Francis Ltd, specializing in the fields of Infectious Diseases, Microbiology, and Plant Science. Since its inception, the journal has provided a platform for innovative research, showcasing a diverse range of studies that delve into the complexities of mycology and its vast implications on health, agriculture, and the environment. With a commendable impact factor and a Q2 ranking in Plant Science as of 2023, MYCOBIOLOGY facilitates the dissemination of vital findings to a global audience of researchers, professionals, and students. In addition to its commitment to high-quality content, MYCOBIOLOGY has embraced open access since 2018, ensuring that the latest advancements in mycological research are readily available to the academic community and the public. By bridging gaps in knowledge and fostering collaboration across disciplines, MYCOBIOLOGY plays a crucial role in advancing our understanding of fungal biology and its myriad applications.

MYCOLOGIA, published by Taylor & Francis Inc, is a prestigious journal that has been at the forefront of fungal research since its inception, with converging years of publication from 1945 to 2024. This interdisciplinary journal, identified by ISSN 0027-5514 and E-ISSN 1557-2536, stands out in various scientific categories, achieving Q1 rankings in Ecology, Evolution, Behavior and Systematics, as well as Plant Science, alongside strong performances in Cell Biology and Molecular Biology categories. With an impact factor that reflects its significance in the field, MYCOLOGIA appeals to a diverse audience, including researchers, professionals, and students dedicated to advancing the understanding of fungal biology and its ecological implications. Notably, while it does not currently operate under an Open Access model, the journal remains a vital resource for those pursuing groundbreaking discoveries in mycology and related disciplines.

Fungal Biology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of mycology and its interdisciplinary applications. With an ISSN of 1878-6146 and E-ISSN 1878-6162, this journal serves as a vital platform for researchers and professionals interested in the ecological, evolutionary, and genetic aspects of fungi, as well as their implications in infectious diseases and plant sciences. As of 2023, it proudly holds a Q2 ranking in Ecology, Evolution, Behavior and Systematics and Plant Science, and a Q3 ranking in Genetics and Infectious Diseases, highlighting its significant contribution to these domains. The journal boasts an impressive Scopus rank, including a percentile of 83rd in Ecological studies, ensuring that published research reaches a wide audience and impacts ongoing discourse in the field. With open access options, Fungal Biology encourages the dissemination of high-quality research, aimed to foster collaboration and innovation among scholars and practitioners. With its convergence of knowledge from 2010 to 2024, this journal is instrumental for those advancing the understanding of fungal biology and its myriad applications in environmental and health sciences.

Fungal Ecology, published by Elsevier Science Ltd, is a leading international journal dedicated to the exploration and advancement of our understanding of fungal biology and its ecological significance. With an impressive impact factor and recognized in the second quartile (Q2) across various categories such as Ecological Modeling, Ecology, Ecology, Evolution, Behavior and Systematics, and Plant Science, this journal offers a critical platform for researchers and professionals to disseminate and discuss innovations in fungal ecology. Since its inception in 2008, the journal has built a solid reputation, particularly highlighted by its impressive Scopus rankings, including a top percentile status in ecological fields. Researchers are encouraged to submit their findings that contribute to the understanding of the ecological roles of fungi, their interactions within ecosystems, and their applications in environmental science. Although the journal does not offer open access, it remains a vital resource for academics and practitioners aiming to stay ahead in the rapidly evolving fields of fungal research and ecology. Located in the vibrant heart of the Netherlands, the journal continues to foster scholarly engagement and collaboration among scientists globally.

Journal of Fungi is a premier open-access journal published by MDPI, dedicated to advancing the understanding of fungal biology in its myriad forms. Since its inception in 2015, it has become a vital resource in the fields of ecology, evolution, and plant sciences, attaining notable rankings in Scopus, including Q1 status in Ecology, Evolution, Behavior and Systematics, and Plant Science, with a Q2 ranking in Microbiology (medical). The journal fosters a collaborative platform for researchers, professionals, and students by providing unrestricted access to high-quality, peer-reviewed articles, which encourages the dissemination of innovative findings and methodologies relevant to fungal research. Designed to cater to a global audience, the Journal of Fungi has established its significance in the scientific community, especially from its base in Switzerland, where it continues to contribute to the ongoing discourse in mycology and beyond. With its commitment to open access since its launch and its continuous support for groundbreaking research, the journal plays a crucial role in driving forward the scientific inquiry and ecological awareness in fungal studies.

MYCOSCIENCE, published by the Mycological Society of Japan, is a prominent peer-reviewed journal that serves as an essential resource in the fields of ecology, evolution, behavior, and systematics, highlighted by its Q2 ranking in the 2023 category quartiles. Established in 1994 and continuing through 2024, the journal focuses on mycological research, providing insights into the interconnected worlds of fungi and their ecological roles. With an ISSN of 1340-3540 and an E-ISSN of 1618-2545, MYCOSCIENCE aims to disseminate high-quality research that addresses current issues and trends within the discipline. Despite not being an open-access journal, it makes a significant contribution to advancing fungal biology and its applications in agriculture and environmental science, making it an invaluable asset for researchers, professionals, and students alike. Located in the vibrant academic environment of Tokyo, Japan, MYCOSCIENCE stands out for its dedication to fostering a deeper understanding of mycology and its implications for biodiversity and ecosystem health.

Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.